bretazenil has been researched along with cyclic gmp in 1 studies
Studies (bretazenil) | Trials (bretazenil) | Recent Studies (post-2010) (bretazenil) | Studies (cyclic gmp) | Trials (cyclic gmp) | Recent Studies (post-2010) (cyclic gmp) |
---|---|---|---|---|---|
101 | 8 | 14 | 22,346 | 333 | 4,062 |
Protein | Taxonomy | bretazenil (IC50) | cyclic gmp (IC50) |
---|---|---|---|
Phosphodiesterase | Bos taurus (cattle) | 0.1 | |
cGMP-inhibited 3',5'-cyclic phosphodiesterase B | Homo sapiens (human) | 2.4 | |
cGMP-inhibited 3',5'-cyclic phosphodiesterase A | Homo sapiens (human) | 2.4 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bonetti, EP; Burkard, WP; Cumin, R; Haefely, WE; Martin, JR; Pieri, L; Schaffner, R | 1 |
1 other study(ies) available for bretazenil and cyclic gmp
Article | Year |
---|---|
Ro 16-6028: a novel anxiolytic acting as a partial agonist at the benzodiazepine receptor.
Topics: Animals; Anti-Anxiety Agents; Anticonvulsants; Behavior, Animal; Benzodiazepinones; Cats; Conflict, Psychological; Cyclic GMP; Diazepam; Dogs; Flunitrazepam; Mice; Rats; Receptors, GABA-A; Saimiri; Substance Withdrawal Syndrome | 1988 |